SCL

SCL Long-Term Debt

$289.10MQuarterly · USD

Period ending:

SCL FY Long-Term DebtUSD
SCL FY Long-Term Debt1985-12-31: $37.00M1986-12-31: $34.90M1987-12-31: $44.40M1988-12-31: $45.40M1989-12-31: $68.60M1990-12-31: $77.30M1991-12-31: $89.80M1992-12-31: $90.50M1993-12-31: $89.70M1994-12-31: $89.80M1995-12-31: $109.00M1996-12-31: $102.60M1997-12-31: $94.90M1998-12-31: $107.70M1999-12-31: $107.40M2000-12-31: $96.47M2001-12-31: $109.59M2002-12-31: $104.30M2003-12-31: $92.00M2004-12-31: $94.02M2005-12-31: $108.95M2006-12-31: $107.40M2007-12-31: $96.94M2008-12-31: $104.73M2009-12-31: $93.91M2010-12-31: $159.96M2011-12-31: $164.97M2012-12-31: $149.56M2013-12-31: $235.25M2014-12-31: $246.90M2015-12-31: $312.55M2016-12-31: $288.86M2017-12-31: $268.30M2018-12-31: $239.02M2019-12-31: $228.19M2020-12-31: $212.38M2021-12-31: $379.53M2022-12-31: $505.59M2023-12-31: $459.27M2024-12-31: $390.02M2025-12-31: $390.32M$505.59M$0.00
1985-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

SCL long-term debt history

Debt obligations due beyond one year. The available annual fiscal periods series contains 41 observations from Dec 31, 1985 to Dec 31, 2025.

Stepan Long-Term Debt — Annual fiscal periods (USD)
Period endingLong-Term Debt (USD)
390,315,000
390,024,000
459,274,000
505,588,000
379,530,000
212,379,000
228,186,000
239,022,000
268,299,000
288,859,000
312,548,000
246,897,000
235,246,000
149,564,000
164,967,000
159,963,000
93,911,000
104,725,000
96,939,000
107,403,000
108,945,000
94,018,000
92,004,000
104,304,000
109,588,000
96,466,000
107,400,000
107,700,000
94,900,000
102,600,000
109,000,000
89,800,000
89,700,000
90,500,000
89,800,000
77,300,000
68,600,000
45,400,000
44,400,000
34,900,000
37,000,000

Compare long-term debt

All SCL financial metrics · SCL stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.